Journal Watch · Cell Systems · 2026

Mechanistic modeling of recessive disease through allelic integration of variant effects.

This framework provides a broadly applicable strategy for the mechanistic interpretation of variants in recessive enzymes.

Çubuk H, Plech M, Aslanzadeh V et al.Cell Systems3 min readPharma relevance 30/100

DOI: 10.1016/j.cels.2026.101595PMID: 42019493Study type: research study

TL;DR

This framework provides a broadly applicable strategy for the mechanistic interpretation of variants in recessive enzymes.

Key findings

  • We applied this approach to adenylosuccinate lyase (ADSL), quantifying the effects of >8,000 coding variants in a yeast-based DMS assay.
  • The inferred activities separated pathogenic from benign alleles, and the bi-allelic scores correlated strongly with biochemical measurements and clinical outcomes, outperforming existing predictors.
  • This framework provides a broadly applicable strategy for the mechanistic interpretation of variants in recessive enzymes.

What they did

Here, we describe a method for inferring enzymatic activities for thousands of variants by running two fitness assays at different expression levels and modeling the nonlinear activity-fitness relationship. These inferred activities allow the computation of a bi-allelic pathogenicity score that captures the joint effect of two alleles.

Full abstract (original)

Background: Interpreting variants in recessive diseases is difficult because clinical severity depends on the combined function of both alleles. Deep mutational scanning (DMS) experiments can provide functional measurements at scale, but their scores often relate nonlinearly to true biochemical activity.

What they did: Here, we describe a method for inferring enzymatic activities for thousands of variants by running two fitness assays at different expression levels and modeling the nonlinear activity-fitness relationship. These inferred activities allow the computation of a bi-allelic pathogenicity score that captures the joint effect of two alleles.

Results & conclusions: We applied this approach to adenylosuccinate lyase (ADSL), quantifying the effects of >8,000 coding variants in a yeast-based DMS assay. The inferred activities separated pathogenic from benign alleles, and the bi-allelic scores correlated strongly with biochemical measurements and clinical outcomes, outperforming existing predictors. This framework provides a broadly applicable strategy for the mechanistic interpretation of variants in recessive enzymes.

Abstract © the authors / Cell Systems (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1016/j.cels.2026.101595 · PubMed 42019493.

Why it matters for pharma & biotech

  • Relevant to Biotechnology & Methods teams tracking Cell Systems for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Cell Systems study find?

This framework provides a broadly applicable strategy for the mechanistic interpretation of variants in recessive enzymes.

What type of study is this?

It is a research study, published in Cell Systems in 2026. Here, we describe a method for inferring enzymatic activities for thousands of variants by running two fitness assays at different expression levels and modeling the nonlinear activity-fitness relationship.

Where can I read the original paper?

The original is at the publisher via DOI 10.1016/j.cels.2026.101595. PubMed ID: 42019493. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Çubuk H, Plech M, Aslanzadeh V et al.. Mechanistic modeling of recessive disease through allelic integration of variant effects.. Cell Systems (2026). DOI: 10.1016/j.cels.2026.101595.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/mechanistic-modeling-of-recessive-disease-through-allelic-integration-of-101595/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides